X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (34693) 34693
Book Review (9287) 9287
Publication (3604) 3604
Book Chapter (274) 274
Newsletter (234) 234
Conference Proceeding (85) 85
Book / eBook (32) 32
Dissertation (22) 22
Newspaper Article (17) 17
Magazine Article (13) 13
Web Resource (10) 10
Reference (4) 4
Paper (2) 2
Presentation (2) 2
Trade Publication Article (2) 2
Data Set (1) 1
Government Document (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (29155) 29155
humans (27521) 27521
oncology (14418) 14418
hematology (13238) 13238
acute myeloid-leukemia (11763) 11763
female (11200) 11200
male (11133) 11133
cancer (9078) 9078
leukemia (8630) 8630
middle aged (8211) 8211
adult (8068) 8068
animals (6744) 6744
aged (6350) 6350
acute myeloid leukemia (5050) 5050
research (4503) 4503
adolescent (4333) 4333
chemotherapy (3773) 3773
mice (3734) 3734
prognosis (3711) 3711
transplantation (3706) 3706
acute lymphoblastic-leukemia (3683) 3683
stem cells (3615) 3615
leukemia, myeloid, acute - genetics (3576) 3576
mutation (3434) 3434
apoptosis (3358) 3358
analysis (3282) 3282
care and treatment (3281) 3281
immunology (3245) 3245
child (3230) 3230
health aspects (3198) 3198
genetic aspects (3142) 3142
cell biology (3132) 3132
chronic myeloid-leukemia (3070) 3070
expression (2918) 2918
acute myelogenous leukemia (2778) 2778
cell line, tumor (2735) 2735
treatment outcome (2729) 2729
hemic and lymphatic diseases (2722) 2722
article (2623) 2623
gene expression (2599) 2599
aged, 80 and over (2478) 2478
chronic myelogenous leukemia (2437) 2437
leukemia, myeloid, acute - drug therapy (2408) 2408
hematology, oncology and palliative medicine (2397) 2397
chronic myeloid leukemia (2391) 2391
antineoplastic agents - therapeutic use (2328) 2328
hematopoietic stem cells (2322) 2322
leukemia, myeloid, acute - pathology (2296) 2296
acute disease (2285) 2285
risk factors (2263) 2263
young adult (2255) 2255
bone marrow (2254) 2254
tumors (2235) 2235
biochemistry & molecular biology (2176) 2176
myelodysplastic syndromes (2157) 2157
child, preschool (2140) 2140
proteins (2116) 2116
medicine & public health (2091) 2091
myelodysplastic syndrome (2080) 2080
bone-marrow-transplantation (2074) 2074
genetics & heredity (2022) 2022
therapy (2015) 2015
abridged index medicus (2011) 2011
myeloid leukemia (1998) 1998
aml (1956) 1956
leukemia, myeloid, acute - therapy (1843) 1843
medicine, research & experimental (1823) 1823
antineoplastic agents - pharmacology (1821) 1821
survival (1799) 1799
retrospective studies (1784) 1784
pharmacology & pharmacy (1760) 1760
stem-cell transplantation (1711) 1711
cells (1704) 1704
immunotherapy (1679) 1679
signal transduction (1664) 1664
genes (1591) 1591
transplantation, homologous (1585) 1585
diagnosis (1583) 1583
infant (1583) 1583
antineoplastic combined chemotherapy protocols - therapeutic use (1560) 1560
apoptosis - drug effects (1540) 1540
flow cytometry (1509) 1509
patients (1497) 1497
physiological aspects (1492) 1492
myeloid-leukemia (1481) 1481
development and progression (1475) 1475
chronic lymphocytic-leukemia (1467) 1467
differentiation (1461) 1461
hematopoietic stem cell transplantation (1405) 1405
gene (1392) 1392
medicine (1331) 1331
mutations (1325) 1325
survival analysis (1306) 1306
cell proliferation (1302) 1302
leukemia, myeloid, acute - metabolism (1301) 1301
pathology (1301) 1301
myelodysplastic syndromes - genetics (1299) 1299
kinases (1291) 1291
recurrence (1289) 1289
leukemia, myeloid, acute - mortality (1274) 1274
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (34701) 34701
Japanese (103) 103
French (98) 98
German (61) 61
Chinese (50) 50
Spanish (41) 41
Korean (33) 33
Russian (29) 29
Polish (19) 19
Hungarian (11) 11
Portuguese (10) 10
Italian (8) 8
Turkish (7) 7
Croatian (4) 4
Dutch (4) 4
Czech (3) 3
Serbian (3) 3
Ukrainian (3) 3
Danish (2) 2
Romanian (2) 2
Bosnian (1) 1
Norwegian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2008, ISBN 3540723021, x, 294
Better therapy of acute leukemias depends ultimately on better understanding of the distinction between leukemic and normal progenitor cells. Thus, several... 
Leukemia, Myeloid, Acute | Precursor Cell Lymphoblastic Leukemia-Lymphoma
Book
Current hematologic malignancy reports, ISSN 1558-8211, 2006
Journal
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2011, Volume 108, Issue 22, pp. 9184 - 9189
MicroRNA miR-146a has been implicated as a negative feedback regulator of NF-κB activation. Knockout of the miR-146a gene in C57BL/6 mice leads to... 
Spleen | Myeloid cells | MicroRNA | Sarcoma | B lymphocytes | Splenocytes | Bone marrow | Mice | Bone marrow cells | Tumors | Noncoding RNA | Inflammation | Myelofibrosis | Cancer | TARGET | SYSTEM | myelofibrosis | ACTIVATION | noncoding RNA | MULTIDISCIPLINARY SCIENCES | P50 | IRAK1 | inflammation | IMMUNE-RESPONSES | cancer | MIR-146A | MICRORNA SIGNATURES | Biological Sciences
Journal Article
2010, ISBN 1846926149
Provides a visual presentation of myeloproliferative neoplasms and myeloid leukaemia, meeting the needs of haematologists and clinical chemists. Covers... 
Medicine | Myeloid leukemia | Bone marrow | Diagnosis | Myeloproliferative disorders | Tumors | Diseases
Web Resource
Nature Genetics, ISSN 1061-4036, 08/2013, Volume 45, Issue 8, pp. 942 - 946
Journal Article
Blood, ISSN 0006-4971, 2013, Volume 122, Issue 11, pp. 1987 - 1989
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2012, Volume 156, Issue 1, pp. 76 - 88
The PRDM16 (1p36) gene is rearranged in acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) with t(1;3)(p36;q21), sharing characteristics with AML... 
myelodysplastic syndrome | 1p36 | acute myeloid leukaemia | lymphoid malignancy | PRDM16 | Acute myeloid leukaemia | Lymphoid malignancy | Myelodysplastic syndrome | CELLS | BONE-MARROW | IDENTIFICATION | TRANSCRIPTS | ACUTE LYMPHOBLASTIC-LEUKEMIA | RUNX1-PRDM16 FUSION | GENE-EXPRESSION | MEL1 | PATIENT | HEMATOLOGY | T(1/3)(P36,Q21) | Translocation, Genetic | Prognosis | Chromosome Breakpoints | Humans | Middle Aged | Child, Preschool | Male | Young Adult | Chromosomes, Human, Pair 1 | Base Sequence | Aged, 80 and over | Adult | Female | Child | Gene Order | Chromosome Banding | Kaplan-Meier Estimate | Lymphoma - genetics | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Leukemia, Myeloid, Acute - mortality | Myelodysplastic Syndromes - diagnosis | Leukemia, Myeloid, Acute - diagnosis | Oncogene Proteins, Fusion - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Adolescent | Myelodysplastic Syndromes - mortality | Aged | Myelodysplastic Syndromes - genetics | Leukemia, Myeloid, Acute - genetics | Fluorescence | DNA binding proteins | Leukemia | Genes | Medical genetics | CD34 antigen | Translocation | Breakpoints | Transcription factors | Karyotypes | Data processing | Malignancy | Survival | Chromosome 1 | Promoters | Polymerase chain reaction | Chromosome translocations | Fluorescence in situ hybridization | chromosome 3 | Bone marrow | gene rearrangement | Fusion protein | Age | Index Medicus
Journal Article
Journal Article
Cancer Science, ISSN 1347-9032, 05/2019, Volume 110, Issue 5, pp. 1686 - 1694
We evaluated the safety, efficacy, pharmacokinetics, pharmacodynamics and predictive biomarkers of tirabrutinib, a second‐generation, enhanced‐selectivity... 
B‐cell non−Hodgkin lymphoma | tirabrutinib | chronic lymphocytic leukemia | B‐cell malignancy | safety | Humans | Middle Aged | Imidazoles - administration & dosage | Neoplasm Recurrence, Local - drug therapy | Male | Imidazoles - pharmacokinetics | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Protein Kinase Inhibitors - adverse effects | Tumor Suppressor Protein p53 - genetics | Aged, 80 and over | Female | Protein Kinase Inhibitors - pharmacokinetics | Drug Administration Schedule | Pyrimidines - administration & dosage | Imidazoles - adverse effects | Japan | Myeloid Differentiation Factor 88 - genetics | Treatment Outcome | Protein Kinase Inhibitors - administration & dosage | Pyrimidines - adverse effects | Pyrimidines - pharmacokinetics | Neoplasm Recurrence, Local - genetics | Aged | CD79 Antigens - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Medical research | Care and treatment | Relapse | Leukemia | Clinical trials | Medicine, Experimental | Lymphomas | Tumor proteins | Diseases | Disease | Laboratories | Toxicity | p53 Protein | Vomiting | Drug dosages | Protein-tyrosine kinase | Neutropenia | Tyrosine | Pharmacodynamics | Chronic lymphatic leukemia | Leukopenia | Lymphatic leukemia | Patients | Lymphoma | Bruton's tyrosine kinase | Pneumonitis | Lymphocytes B | Technical communication | Response rates | Biomarkers | MyD88 protein | Mutation | Pharmacokinetics | Hodgkin's disease | Pharmaceuticals | Index Medicus | Original
Journal Article